Skip to main content
Robert Moen, MD, Allergy & Immunology, Seattle, WA

Robert Chas Moen MD PhD

Allergy & Immunology•Seattle, WA

President & CEO Copernicus Therapeutics, Inc.

Join to View Full Profile

  • U of WA Sch of MedSeattle, WA 98195

Dr. Moen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Moen's Full ProfileAlready have an account?

Education & Training

  • University of Washington
    University of WashingtonPhD, Biochemistry, 1972 - 1979
  • University of Washington
    University of WashingtonMD, Medical Scientist, 1972 - 1979
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1979
  • Harvard University
    Harvard UniversityBA, Biochemistry, Magna Cum Laude, 1972 - 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2026
  • MD State Medical License
    MD State Medical License 1990 - 2017
  • DC State Medical License
    DC State Medical License 1991 - 1992
  • WI State Medical License
    WI State Medical License 1982 - 1991
  • Allergy & Immunology
    American Board of Allergy and Immunology Allergy & Immunology
  • Pediatrics
    American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Small Business Innovation Research Grant 1989, 1990
  • First Recipient of the Immune Deficiency Foundation Fellowship Award 1983, 1985
  • American Cancer Society Institutional Research Grant U of Wisconsin - Madison, 1984, 1985

Publications & Presentations

Journal Articles

  • Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients.  
    Brenner, M.K., Rill, D.R., Holladay, M.S., Heslop, H.E., Moen, R.C., Buschle, M., Krance, R.A., Anderson, W.F., and Ihle, J.N, Lancet
  • Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo.  
    Ziady, A-G., Gedeon, C.R., Miller, T., Quan, W., Payne, J.M., Hyatt, S.L., Fink, T.L., Muhammad, O., Oette, S., Kowalczyk, T., Pasumarthy, M.K., Moen, R.C., Cooper, M...., Mol. Ther
  • Amphotropic murine leukemia retrovirus is not an acute pathogen for primates.  
    Cornetta, K., Moen, R.C., Culver, K., Morgan, R.A., McLachlin, J.R., Sturm, S., Selegue, J.E., London, W.T., Blaese, R.M., and Anderson, W.F, Human Gene Therapy

Books/Book Chapters

  • Depletion of T-cells from human bone marrow with monoclonal antibodies CT-2 and complement for prevention of graft-versus-host disease in allogeneic histocompatible and nonhistocompatible bone... 
    Trigg, M., Bozdech, M.J., Billing, R., Sondel,P., Horowitz, S., Exten, R., Finlay, J., Moen, R., Longo, W., Erickson, C. and Peterson, A
  • Drug Technology Regulation: Scientific Basis and Practices. 
    Chapter: Advances towards somatic gene replacement therapy 
    Page 439 - 455Samid, D., Anderson, W.F., and Moen, R.CEditors: Chiu and Gueriguian.Marcel Dekker, New York
  • Recent Advances in Haematology 7. 
    Chapter: Current and prospective gene therapy protocols 
    Moen, R.CEditors: Brenner and Hoffbrand.

Press Mentions

  • New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients with Atrial Fibrillation
    New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients with Atrial FibrillationAugust 3rd, 2021

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Robert Moen, Dr. Robert Moen, MD, Dr. R Moen, Dr. Robert Chas Moen